‘Chaperone’ compounds offer new approach to Alzheimer’s treatment

April 21, 2014

Chaperone-1

“Our findings identify a novel class of pharmacologic agents that are designed to treat neurologic disease by targeting a defect in cell biology, rather than a defect in molecular biology,” said Scott Small, MD, the Boris and Rose Katz Professor of Neurology.  “This approach may prove to be safer and more effective than conventional treatments for neurologic disease, which typically target single proteins.”

A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer’s disease involving the so-called retromer protein complex. Retromer plays a vital role in neurons, steering amyloid precursor protein (APP) away from a region of the cell where APP is cleaved, creating the potentially toxic byproduct amyloid-beta, which is thought to contribute to the development of Alzheimer’s.

Using computer-based virtual screening, the researchers identified a new class of compounds, called pharmacologic chaperones, that can significantly increase retromer levels and decrease amyloid-beta levels in cultured hippocampal neurons, without apparent cell toxicity. The study was published today in the online edition of the journal Nature Chemical Biology.

“Our findings identify a novel class of pharmacologic agents that are designed to treat neurologic disease by targeting a defect in cell biology, rather than a defect in molecular biology,” said Scott Small, MD, the Boris and Rose Katz Professor of Neurology, Director of the Alzheimer’s Disease Research Center in the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain at CUMC, and a senior author of the paper. “This approach may prove to be safer and more effective than conventional treatments for neurologic disease, which typically target single proteins.”

In 2005, Dr. Small and his colleagues showed that retromer is deficient in the brains of patients with Alzheimer’s disease. In cultured neurons, they showed that reducing retromer levels raised amyloid-beta levels, while increasing retromer levels had the opposite effect. Three years later, he showed that reducing retromer had the same effect in animal models, and that these changes led to Alzheimer’s-like symptoms. Retromer abnormalities have also been observed in Parkinson’s disease.

In discussions at a scientific meeting, Dr. Small and co-senior authors Gregory A. Petsko, DPhil, Arthur J. Mahon Professor of Neurology and Neuroscience in the Feil Family Brain and Mind Research Institute and Director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medical College, and Dagmar Ringe, PhD, Harold and Bernice Davis Professor in the Departments of Biochemistry and Chemistry and in the Rosenstiel Basic Medical Sciences Research Center at Brandeis University, began wondering if there was a way to stabilize retromer (that is, prevent it from degrading) and bolster its function. “The idea that it would be beneficial to protect a protein’s structure is one that nature figured out a long time ago,” said Dr. Petsko. “We’re just learning how to do that pharmacologically.”

Other researchers had already determined retromer’s three-dimensional structure. “Our challenge was to find small molecules—or pharmacologic chaperones—that could bind to retromer’s weak point and stabilize the whole protein complex,” said Dr. Ringe.

This was accomplished through computerized virtual, or in silico, screening of known chemical compounds, simulating how the compounds might dock with the retromer protein complex. (In conventional screening, compounds are physically tested to see whether they interact with the intended target, a costlier and lengthier process.) The screening identified 100 potential retromer-stabilizing candidates, 24 of which showed particular promise. Of those, one compound, called R55, was found to significantly increase the stability of retromer when the complex was subjected to heat stress.

The researchers then looked at how R55 affected neurons of the hippocampus, a key brain structure involved in learning and memory. “One concern was that this compound would be toxic,” said Dr. Diego Berman, assistant professor of clinical pathology and cell biology at CUMC and a lead author. “But R55 was found to be relatively non-toxic in mouse neurons in cell culture.”

More important, a subsequent experiment showed that the compound significantly increased retromer levels and decreased amyloid-beta levels in cultured neurons taken from healthy mice and from a mouse model of Alzheimer’s. The researchers are currently testing the clinical effects of R55 in the actual mouse model .

“The odds that this particular compound will pan out are low, but the paper provides a proof of principle for the efficacy of retromer pharmacologic chaperones,” said Dr. Petsko. “While we’re testing R55, we will be developing chemical analogs in the hope of finding compounds that are more effective.”


Story Source:

The above story is based on materials provided by Columbia University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Vincent J Mecozzi, Diego E Berman, Sabrina Simoes, Chris Vetanovetz, Mehraj R Awal, Vivek M Patel, Remy T Schneider, Gregory A Petsko, Dagmar Ringe, Scott A Small. Pharmacological chaperones stabilize retromer to limit APP processing. Nature Chemical Biology, 2014; DOI: 10.1038/nchembio.1508

http://www.sciencedaily.com/releases/2014/04/140420131519.htm

 

Advertisements

20 thoughts on “‘Chaperone’ compounds offer new approach to Alzheimer’s treatment

  1. Great blog here! Also your web site loads up very fast!
    What host are you using? Can I get your affiliate link to your host?
    I wish my site loaded up as fast as yours lol

    • Amparo says:

      First of all I would like to say wonderful blog! I had a quick question in which I’d like to ask if you
      don’t mind. I was curious to know how you center
      yourself and clear your mind prior to writing.
      I have had a tough time clearing my thoughts in getting my ideas out there.
      I truly do enjoy writing but it just seems like the first 10 to 15 minutes are lost simply just trying to figure out how to begin. Any suggestions or hints?
      Many thanks!

  2. For now, the services provided by Caviar will remain separate.

    The most notable is its partnerships with restaurants that don’t provide delivery services to customers.

    Unfortunately, it’s the MMO equivalent of closing the barn door after the horse is out.

  3. An impressive share! I have just forwarded this onto a co-worker who had been doing a little research on this.
    And he actually ordered me lunch because I discovered it for him…
    lol. So allow me to reword this…. Thank YOU for the meal!!
    But yeah, thanx for spending the time to talk about this issue here
    on your web page.

  4. Saga pet says:

    Please let me know if you’re looking for a article writer for your blog.
    You have some really great posts and I think I would be a good asset.
    If you ever want to take some of the load off, I’d love to write some material for your blog in exchange for
    a link back to mine. Please blast me an email if interested.
    Thank you!

  5. battlecampcheats4u.wordpress.com says:

    Thanks for any other magnificent post. Where else may just anybody get
    that type of information in such an ideal
    manner of writing? I have a presentation next week, and
    I’m at the search for such information.

  6. Today, I went to the beach with my children. I found a sea shell and gave it to my 4 year old daughter and said “You can hear the ocean if you put this to your ear.” She put the shell to her ear and screamed.

    There was a hermit crab inside and it pinched her ear.
    She never wants to go back! LoL I know this is completely off topic but I
    had to tell someone!

  7. When someone writes an article he/she retains the plan of a
    user in his/her mind that how a user can understand it.
    So that’s why this piece of writing is great. Thanks!

  8. If you’re ready to start using intercourse toys, please make sure that to learn my different article: The best way to
    Introduce Sex Toys in the bed room. Crucial factor
    in your accomplice to know is that the intercourse toy is not going
    to interchange them!

  9. 4) “Life,” says Marvin dolefully, “loathe it or ignore it, you can’t like it. Then, in a process of creation and destruction, they formed the landscape as we know it today. Now that – Mario has his own ship, you’re free to explore the available galaxy as much as you like.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s